Celltrion completes enrolment for global phase II clinical trial with Covid-19 treatment candidate

This article was originally published here

The global Phase II clinical trial is a randomised, double-blind, placebo-controlled and parallel-group trial designed to evaluate the efficacy and safety of CT-P59 in combination with standard of

The post Celltrion completes enrolment for global phase II clinical trial with Covid-19 treatment candidate appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply